Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,861 | 30 | 65.9% |
| Travel and Lodging | $964.56 | 4 | 34.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,307 | 7 | $0 (2017) |
| ACADIA Pharmaceuticals Inc | $703.13 | 8 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $309.35 | 3 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $269.08 | 7 | $0 (2022) |
| Avanir Pharmaceuticals, Inc. | $86.32 | 6 | $0 (2022) |
| Mylan Specialty L.P. | $62.11 | 1 | $0 (2021) |
| Otsuka America Pharmaceutical, Inc. | $49.55 | 1 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $39.01 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $283.46 | 4 | Neurocrine Biosciences, Inc. ($195.72) |
| 2023 | $163.18 | 2 | Neurocrine Biosciences, Inc. ($113.63) |
| 2022 | $215.49 | 5 | ACADIA Pharmaceuticals Inc ($125.00) |
| 2021 | $374.92 | 9 | Sunovion Pharmaceuticals Inc. ($141.54) |
| 2019 | $349.48 | 5 | ACADIA Pharmaceuticals Inc ($250.00) |
| 2018 | $120.24 | 1 | ACADIA Pharmaceuticals Inc ($120.24) |
| 2017 | $1,319 | 8 | Novartis Pharmaceuticals Corporation ($1,307) |
All Payment Transactions
34 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/10/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $73.65 | General |
| Category: Neuropsychiatry | ||||||
| 08/10/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $59.61 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 07/16/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $28.13 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 03/09/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $122.07 | General |
| Category: Neuropsychiatry | ||||||
| 08/05/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $49.55 | General |
| Category: PSYCHIATRY | ||||||
| 03/10/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $113.63 | General |
| Category: Neuropsychiatry | ||||||
| 10/03/2022 | Avanir Pharmaceuticals, Inc. | Nuedexta (Drug) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 08/05/2022 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $85.53 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 08/04/2022 | Sunovion Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $55.29 | General |
| 06/08/2022 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $39.47 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 01/14/2022 | Avanir Pharmaceuticals, Inc. | Nuedexta (Drug) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 09/24/2021 | Avanir Pharmaceuticals, Inc. | Nuedexta (Drug) | Food and Beverage | In-kind items and services | $11.77 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 08/11/2021 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $62.11 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 08/07/2021 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $40.94 | General |
| Category: CNS | ||||||
| 08/07/2021 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $40.94 | General |
| Category: CNS | ||||||
| 08/06/2021 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $120.15 | General |
| Category: PDP | ||||||
| 08/05/2021 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $59.66 | General |
| Category: RESPIRATORY | ||||||
| 07/14/2021 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $12.78 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 06/16/2021 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $11.37 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 03/19/2021 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 08/22/2019 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: RESPIRATORY | ||||||
| 08/10/2019 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $44.29 | General |
| Category: CNS | ||||||
| 08/09/2019 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 08/09/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $39.01 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/08/2019 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 651 | 1,322 | $269,207 | $98,202 |
| 2022 | 4 | 793 | 1,313 | $272,108 | $90,538 |
| 2021 | 6 | 820 | 1,365 | $284,090 | $96,076 |
| 2020 | 6 | 975 | 1,822 | $396,352 | $131,044 |
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 207 | 684 | $103,968 | $38,691 | 37.2% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 273 | 358 | $102,746 | $35,325 | 34.4% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 119 | 226 | $45,652 | $18,426 | 40.4% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Office | 2023 | 35 | 37 | $10,619 | $3,335 | 31.4% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 17 | 17 | $6,222 | $2,424 | 39.0% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Facility | 2022 | 358 | 419 | $119,815 | $40,418 | 33.7% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 229 | 616 | $93,351 | $31,895 | 34.2% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 132 | 186 | $37,378 | $11,688 | 31.3% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Office | 2022 | 33 | 37 | $10,565 | $3,386 | 32.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 15 | 19 | $4,802 | $1,052 | 21.9% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 11 | 21 | $3,183 | $1,052 | 33.0% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Office | 2022 | 15 | 15 | $3,014 | $1,048 | 34.8% |
| 99305 | Initial nursing facility visit, typically 35 minutes per day | Facility | 2021 | 346 | 406 | $115,710 | $39,755 | 34.4% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2021 | 223 | 577 | $87,127 | $30,110 | 34.6% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2021 | 153 | 261 | $52,200 | $17,704 | 33.9% |
| 99305 | Initial nursing facility visit, typically 35 minutes per day | Office | 2021 | 26 | 27 | $7,695 | $2,624 | 34.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 17 | 29 | $6,844 | $1,920 | 28.1% |
| 99306 | Initial nursing facility visit, typically 45 minutes per day | Facility | 2021 | 16 | 17 | $6,205 | $1,724 | 27.8% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Office | 2021 | 15 | 19 | $3,800 | $1,108 | 29.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 12 | 13 | $2,093 | $590.38 | 28.2% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2021 | 12 | 16 | $2,416 | $540.50 | 22.4% |
| 99305 | Initial nursing facility visit, typically 35 minutes per day | Facility | 2020 | 384 | 460 | $119,773 | $46,363 | 38.7% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2020 | 252 | 767 | $141,337 | $41,437 | 29.3% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2020 | 188 | 372 | $84,837 | $26,085 | 30.7% |
| 99305 | Initial nursing facility visit, typically 35 minutes per day | Office | 2020 | 41 | 41 | $11,168 | $4,009 | 35.9% |
About Dr. Kent Davis, MD
Dr. Kent Davis, MD is a Internal Medicine healthcare provider based in Tyler, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/17/2005. The National Provider Identifier (NPI) number assigned to this provider is 1548259179.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kent Davis, MD has received a total of $2,825 in payments from pharmaceutical and medical device companies, with $283.46 received in 2024. These payments were reported across 34 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($1,861).
As a Medicare-enrolled provider, Davis has provided services to 3,239 Medicare beneficiaries, totaling 5,822 services with total Medicare billing of $415,860. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Geriatric Medicine
- Location Tyler, TX
- Active Since 10/17/2005
- Last Updated 09/11/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1548259179
Products in Payments
- CNP520 (Drug) $1,019
- NUPLAZID (Drug) $703.13
- INGREZZA (Drug) $309.35
- APTIOM (Drug) $137.95
- LONHALA MAGNAIR (Drug) $75.84
- Yupelri (Drug) $62.11
- REXULTI (Drug) $49.55
- Nuedexta (Drug) $46.97
- NUEDEXTA (Drug) $39.35
- XARELTO (Drug) $39.01
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Tyler
Dr. Pamela Mcshane, M.d, M.D
Internal Medicine — Payments: $243,956
Thomas Buzbee, M.d, M.D
Internal Medicine — Payments: $123,613
Preetham Muskula, Md, MD
Internal Medicine — Payments: $89,345
Dr. Julie Philley, Md, MD
Internal Medicine — Payments: $68,306
Alexandre Petrakian, Md, MD
Internal Medicine — Payments: $37,685
Kai Xia, Md, MD
Internal Medicine — Payments: $24,476